Related Experiment Video

Updated: Apr 19, 2026

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
07:03

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

2.1K

Nonalcoholic fatty liver disease: a challenge for pediatricians

Valerio Nobili1, Naim Alkhouri2, Anna Alisi1

  • 1Hepato-Metabolic Disease Unit, Bambino Gesù Children's Hospital, Italian Scientific Institute for Research and Care, Rome, Italy.

JAMA Pediatrics
|December 16, 2014
PubMed

Insights

Nonalcoholic fatty liver disease (NAFLD) is a growing concern in children, linked to metabolic syndrome. Early diagnosis and lifestyle changes are key to managing this common liver condition and preventing progression.

Area of Science:

  • Pediatric Hepatology
  • Metabolic Disorders
  • Gastroenterology

Background:

  • Nonalcoholic fatty liver disease (NAFLD) is the most frequent pediatric chronic liver disease.
  • It represents the liver manifestation of metabolic syndrome.
  • NAFLD encompasses a spectrum from simple steatosis to nonalcoholic steatohepatitis (NASH), potentially leading to fibrosis and cirrhosis in children.

Purpose of the Study:

  • To provide an updated review of nonalcoholic fatty liver disease (NAFLD) in children.
  • To discuss risk factors, diagnostic challenges, and current/emerging treatments.
  • To highlight the need for noninvasive markers for disease severity.

Main Methods:

  • Review of current literature on pediatric NAFLD.
  • Analysis of risk factors including genetics, environment, and gut microbiome.
  • Evaluation of diagnostic approaches and therapeutic strategies.

Main Results:

  • NAFLD development is multifactorial, influenced by race, genetics, environment, and gut microbiome.
  • Diagnosis of advanced NAFLD can be challenging, often necessitating liver biopsy.
  • Lifestyle modifications and weight loss are primary treatments; probiotics, omega-3 fatty acids, and vitamin E show potential.

Conclusions:

  • Pediatric NAFLD is a significant health issue requiring comprehensive management.
  • Noninvasive biomarkers are crucial for accurate disease staging.
  • Ongoing research explores novel therapeutic targets for NAFLD and NASH in children.

More Related Videos

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis06:26

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

Published on: July 18, 2025

1.2K
Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis05:56

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

720

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.5K
Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
1.2K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
266
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
373
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
17
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
20